The Patent Finder

Terms ending in 2032

Mesoblast, Inc.

Every in-force patent on Mesoblast, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,301,978Method of Treating Graft Versus Host Disease
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 10,550,369Enhanced MSC Preparation
In force
 · Medium confidence
Mesoblast International SARLIn forceMedium confidence
US 8,637,004Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
In force
 · High confidence
Mesoblast International SàrlIn forceHigh confidence
US 10,206,951Methods of Treating Multiple Sclerosis Using STRO-1+ and Tnap+ Multipotential Cells
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 9,265,796Methods of Treating or Preventing Rheumatic Disease
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 9,974,812Methods of Treating or Preventing Rheumatic Disease
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 10,596,199Methods of Treating or Preventing Rheumatic Disease
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 9,642,878Methods for Increasing Osteoblastic Function
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 11,135,249Methods for Increasing Osteoblastic Function
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited